Table of Contents:
1 Report Prologue
2 Introduction
2.1 Introduction
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
4 Market Factor Analysis
4.1 Porters Five Forces
4.1.1 Introduction
4.1.2 Bargaining power of suppliers
4.1.3 Bargaining Power Of Buyers
4.1.4 Threat Of New Entrants
4.1.5 Threat of Substitutes
4.1.6 Rivalry
4.2 Value Chain Analysis
4.2.1 Introduction
4.2.2 Inputs
4.2.3 Research and Development
4.2.4 Drug Development
4.2.5 Manufacturing Process Of Aesthetic Products
4.2.6 Marketing and distribution
4.3 Supply Chain
4.3.1 Introduction
5 Market Dynamics
5.1 Drivers
5.1.1 Growing Demand For Aesthetic Treatments
5.1.2 Technological Advancements In Aesthetic Industry
5.1.3 Effects Of Pollution
5.1.4 Increasing Acceptance Of Facial Aesthetics
5.2 Restrains
5.2.1 Complication During Surgery
5.2.2 Strict regulatory barriers in developing countries
5.2.3 Black Market For Aesthetics Products
5.2.4 Side Effects Associated with Aesthetics Procedures
5.3 Opportunity
6 Global Aesthetics Market By Products
6.1 Implants
6.2 Injectable's
6.3 Energy Based Device
7 Global Aesthetics Market, By Treatment
7.1 Phototherapy Treatments
7.2 Chemical Peels
7.3 Liposuction
7.4 Laser resurfacing
8 Global Aesthetic Market by Application
8.1 Body Shaping / Skin Tightening
8.2 Sub-Dermal Skin Treatment
8.3 Epidermal Skin/Hair Treatment
9 Global Aesthetic Market by Region
9.1 North America
9.1.1 US
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest Of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Republic of Korea
9.3.5 Australia
9.3.6 Rest of Asia Pacific
9.4 Middle East & Africa
9.4.1 UAE
9.4.2 Saudi Arabia
9.4.3 Egypt
9.4.4 Rest of Middle East & Africa
10 Competitive Landscape
11 Company Profile
11.1 Galderma
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.2 Allergan
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Merz Pharma
11.3.1 Company Overview
11.3.2 Product overview
11.3.3 Financial Overview
11.3.4 Key developments
11.3.5 SWOT Analysis
11.4 Valeant Pharmaceuticals
11.4.1 Company Overview
11.4.2 Product overview
11.4.3 Financial Overview
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Integra Lifesciences
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.5.5 Swot Analysis
11.6 Sanofi
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Sinclair
11.7.1 Company overview
11.7.2 Product overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis